SCHEMBL27188917

SCHEMBL27188917

COc1ccc2c(c1)CC(C)(C(=O)OC(C)(C)C)C2=O

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 1/20 0.58
KDM4E B2RXH2 4/20 0.42
ALDH1A1 P00352 4/20 0.42
LMNA P02545 2/20 0.42
HPGD P15428 1/20 0.42
CA1 P00915 1/20 0.41
CA2 P00918 1/20 0.41
CA4 P22748 1/20 0.41
CA7 P43166 1/20 0.41
CA9 Q16790 1/20 0.41
METAP1 P53582 4/20 0.40
PRNP P04156 1/20 0.39
GLA P06280 2/20 0.38
GAA P10253 2/20 0.38
MAPT P10636 1/20 0.38
RAB9A P51151 1/20 0.38
ATM Q13315 1/20 0.38
TDP1 Q9NUW8 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
MALT1 Q9UDY8 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29713980 1.00 SMN1; SMN2 (0.58) SMN1; SMN2KDM4EALDH1A1LMNAHPGD
SCHEMBL27188918 0.82 SMN1; SMN2 (0.61) SMN1; SMN2KDM4EALDH1A1LMNAHPGD
SCHEMBL29597471 0.82 SMN1; SMN2 (0.61) SMN1; SMN2KDM4EALDH1A1LMNAHPGD
SCHEMBL27188924 0.80 L3MBTL1 (0.44) SMN1; SMN2ALDH1A1LMNAMAPTRAB9A
SCHEMBL27188923 0.76 SMN1; SMN2 (0.64) SMN1; SMN2KDM4EALDH1A1LMNAHPGD
SCHEMBL22792662 0.75 STS (0.47) SMN1; SMN2ALDH1A1
SCHEMBL3958079 0.74 SMN1; SMN2 (0.54) SMN1; SMN2KDM4EALDH1A1CA1CA2
SCHEMBL28910708 0.73 SMN1; SMN2 (0.60) SMN1; SMN2KDM4EALDH1A1LMNAHPGD
SCHEMBL28547728 0.73 SMN1; SMN2 (0.60) SMN1; SMN2KDM4EALDH1A1LMNAHPGD
SCHEMBL10341535 0.72 SMN1; SMN2 (0.52) SMN1; SMN2KDM4EALDH1A1HPGDCA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11952335-B2 Process for preparing 1-indanone compounds by intramolecular Friedel-Crafts reaction of alpha,alpha-dialkylmalonate derivatives FIRMENICH SA (CH) 2024-04-09 US claimed
US-20220356143-A1 PROCESS FOR PREPARING 1-INDANONE COMPOUNDS BY INTRAMOLECULAR FRIEDEL-CRAFTS REACTION OF ALPHA,ALPHA-DIALKYLMALONATE DERIVATIVES FIRMENICH SA (CH) 2022-11-10 US claimed
CN-114514219-A Process for the preparation of 1-indanone compounds by intramolecular friedel-crafts reaction of derivatives of α, α -dialkyl malonates 弗门尼舍有限公司 2022-05-17 CN claimed
EP-4013738-B1 PROCESS FOR PREPARING 1-INDANONE COMPOUNDS BY INTRAMOLECULAR FRIEDEL-CRAFTS REACTION OF ALPHA,ALPHA-DIALKYLMALONATE DERIVATIVES FIRMENICH & CIE (CH) 2026-02-25 EP disclosed
US-11952335-B2 Process for preparing 1-indanone compounds by intramolecular Friedel-Crafts reaction of alpha,alpha-dialkylmalonate derivatives FIRMENICH SA (CH) 2024-04-09 US disclosed
US-20220356143-A1 PROCESS FOR PREPARING 1-INDANONE COMPOUNDS BY INTRAMOLECULAR FRIEDEL-CRAFTS REACTION OF ALPHA,ALPHA-DIALKYLMALONATE DERIVATIVES FIRMENICH SA (CH) 2022-11-10 US disclosed
CN-114514219-A Process for the preparation of 1-indanone compounds by intramolecular friedel-crafts reaction of derivatives of α, α -dialkyl malonates 弗门尼舍有限公司 2022-05-17 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11952335-B2 Process for preparing 1-indanone compounds by intramolecular Friedel-Crafts reaction of alpha,alpha-dialkylmalonate derivatives IP6K1, FDFT1, MINK1 SMN1; SMN2 4384/4885KDM4E 2392/4885ALDH1A1 149/4885
US-20220356143-A1 PROCESS FOR PREPARING 1-INDANONE COMPOUNDS BY INTRAMOLECULAR FRIEDEL-CRAFTS REACTION OF ALPHA,ALPHA-DIALKYLMALONATE DERIVATIVES IP6K1, FDFT1, MINK1 SMN1; SMN2 4384/4885KDM4E 2392/4885ALDH1A1 149/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.